[unable to retrieve full-text content]
Building on their recent research focusing on a peptide designed to block the oxidant amplifying function of the cellular sodium-potassium pump, researchers have successfully demonstrated that pNaKtide, can attenuate the development of experimental nonalcoholic fatty liver disease (NAFLD) and atherosclerosis. Research team advances research on metabolic syndrome
Aucun commentaire:
Enregistrer un commentaire